Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders

Leukemia

Volumn 28, Issue 2, 2014, Pages 447-449

  Argentou, N ^a   Vassilopoulos, G ^a   Ioannou, M ^a   Germenis, A E ^a   Speletas, M ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELOID DIFFERENTIATION FACTOR 88;

CANCER GENETICS; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; EXON; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; MONOCLONAL B CELL LYMPHOCYTOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; WALDENSTROEM MACROGLOBULINEMIA;

B-LYMPHOCYTES; CODON; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS;

EID: 84893761445     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.294     Document Type: Letter

References (13)

1. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325-332.
2. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-569.
3. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102: 3759-3764.
4. Waldenstrom J. Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia-a new syndrome? Acta Med Scand 1944; 117: 216-247.
5. Kristinsson SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population based study in Sweden. Blood 2008; 112: 3052-3056.
6. Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 2012; 367: 826-833.
7. Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X et al. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013; 121: 2051-2058.
8. Landgren O, Staudt L. MYD88 L265P somatic mutation in IgM MGUS [letter]. N Engl J Med 2012; 367: 23.
9. Jiménez C, Sebastián E, Del Carmen Chillón M, Giraldo P, Mariano Hernández J, Escalante F et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenströ m's macroglobulinemia. Leukemia 2013; 27: 1722-1728.
10. Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood 2013; 121: 2522-2528.
11. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th edn. IARC Press: Lyon, France, 2008, pp 194-195.
12. Leren TP, Rodningen OK, Rosby O, Solberg K, Berg K. Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads. Biotechniques 1993; 14: 618-623.
13. Zakeri H, Ampaaro G, Chen SM, Spurgeon S, Kwok PY. Peak height patterns in dichloro-rhodamine and energy transfer dye terminator sequencing. Biotechniques 1998; 25: 406-413.